ASAAP Malaria Project

ASAAP is a 48-month-long multicenter clinical trial research to evaluate the efficacy, safety, tolerability and pharmacokinetics of a new combination of antimalarial drugs, with particular focus on its successful application in one of the largest and most vulnerable demographics of Africa – children under five years of age. ASAAP is coordinated by KCCR in Kumasi - Ghana, under the authority of the Kwame Nkrumah University of Science and Technology (KNUST) with 6 other countries (Gabon, Mali, Benin, Burkina Faso, Germany, and France). Both African and European partners are collaborating on equal terms to achieve maximum success from the planned activities.